Last updated: February 27, 2024
Sponsor: Hospital San Jose Tec de Monterrey
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Prevention
Diabetes And Hypertension
Diabetes Mellitus, Type 2
Treatment
Integrative Group Program
Conventional treatment for T2DM
Clinical Study ID
NCT05888454
Dando pasos juntos
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- T2DM diagnosis of less than 5 years
- Age 18 to 80 years
- Current residence in Nuevo León, México
- Availability to attend in-person sessions
- Provides written informed consent
- Able to read and write
Exclusion
Exclusion Criteria:
- Currently under insulin treatment
- T2DM diagnosis more than 5 years ago
- Comorbidities such as active cancer, acquired immunodeficiency (HIV+, AIDS), liver,cardiovascular, renal, pulmonary or thyroid disease.
- History of severe neurologic or psychiatric disease (current or past diagnosis)
- Currently pregnant or intention of pregnancy in the following 3 months
- Males that consume more than 4 alcoholic beverages daily or 14 weekly
- Females that consume more than 3 alcoholic beverages daily or 7 weekly
- Consumption of any illicit drug
Study Design
Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Integrative Group Program
Phase:
Study Start date:
July 24, 2023
Estimated Completion Date:
July 31, 2024
Connect with a study center
Centro Médico Zambrano Hellion, Fundación Santos y de la Garza Evia I.B.P, TecSalud
San Pedro Garza Garcia, Nuevo León 66278
MexicoActive - Recruiting
Centro de Salud Integral, Fundación Santos y de la Garza Evia I.B.P, TecSalud
Santa Catarina, Nuevo León 66369
MexicoActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.